QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Boyonoski, A. C. Articles by Kirkland, J. B. Search for Related Content PubMed PubMed Citation Articles by Boyonoski, A. C. Articles by Kirkland, J. B.

Pharmacological Intakes of Niacin Increase Bone Marrow Poly(ADP-Ribose) and the Latency of Ethylnitrosourea-Induced Carcinogenesis in Rats¹

Ann C. Boyonoski, Jennifer C. Spronck, Robert M. Jacobs^*, Girish M. Shah, Guy G. Poirier^** and James B. Kirkland²

Department of Human Biology and Nutritional Sciences and ^* Department of Pathobiology, University of Guelph, Guelph, ON, Canada N1G 2W1; Laboratory for Skin Cancer Research, Hospital Research Center of University Laval, Ste. Foy, QC, Canada G1V 4G2; and ^** Unit of Health and Environment, Hospital Research Center of University Laval, Ste. Foy, QC, Canada G1V 4G2

²To whom correspondence should be addressed. E-mail: jkirklan{at}uoguelph.ca.

Cancer chemotherapy agents cause short-term leukopenia during treatment and the development of secondary leukemias after recovery from the original disease. We reported that niacin deficiency in rats increases the severity of nitrosourea-induced leukopenia and the subsequent development of cancers. This study was designed to test the effects of supplementing an already high quality diet with pharmacologic levels of niacin. For a period of 4 wk, nontumor-bearing weanling Long-Evans rats were pair-fed AIN-93M diets that were niacin adequate (30 mg/kg diet) or pharmacologically supplemented (4 g/kg diet) with nicotinic acid (NA) or nicotinamide (Nam). One week after the initiation of niacin feeding protocols, ethylnitrosourea (ENU) treatment began (12 doses, 30 mg/kg by gavage, every other day). ENU treatment caused leukopenia, which was not prevented by niacin supplementation. At the end of ENU treatment, all rats were switched to a niacin-adequate diet and monitored. Within 36 wk after the start of treatment, all of the ENU-treated rats either lost 5% of peak body weight or had palpable tumors > 1 cm in diameter, and were necropsied. Supplementation with NA or Nam at 4.0 g/kg diet (combined analysis) increased the latency of the ENU-induced morbidity curve, relative to niacin-adequate controls. Morbidity could be attributed in almost all cases to some form of neoplasm, with leukemias the predominant form. In short-term studies, supplementation with either NA or Nam caused dramatic increases in bone marrow NAD⁺ (1- to 1.5-fold), basal poly(ADP-ribose) (3- to 5-fold) and ENU-induced poly(ADP-ribose) levels (1.5-fold). These data show that supplementation of a niacin-adequate, high quality diet with pharmacologic levels of nicotinic acid or nicotinamide increases NAD⁺ and poly(ADP-ribose) levels in bone marrow and may be protective against DNA damage.

KEY WORDS: • niacin • leukemia • nitrosourea • poly(ADP-ribose) • chemotherapy • rats

This article has been cited by other articles:

				J. B. Kirkland Niacin status and treatment-related leukemogenesis Mol. Cancer Ther., April 1, 2009; 8(4): 725 - 732. [Abstract] [Full Text] [PDF]

				A. A. Sauve NAD+ and Vitamin B3: From Metabolism to Therapies J. Pharmacol. Exp. Ther., March 1, 2008; 324(3): 883 - 893. [Abstract] [Full Text] [PDF]

				G. S. Young, E. L. Jacobson, and J. B. Kirkland Water Maze Performance in Young Male Long-Evans Rats Is Inversely Affected by Dietary Intakes of Niacin and May Be Linked to Levels of the NAD+ Metabolite cADPR J. Nutr., April 1, 2007; 137(4): 1050 - 1057. [Abstract] [Full Text] [PDF]